Board Meeting8 May 2026, 04:41 pm
Kwality Pharmaceuticals Board Meeting on May 19, 2026
AI Summary
Kwality Pharmaceuticals Ltd has scheduled a Board of Directors meeting on May 19, 2026, to consider and approve the Standalone & Consolidated Audited Financial Results for the Fourth Quarter and Financial Year Ended on March 31, 2026. The trading window for dealing in the company's securities will be closed until 48 hours after the results are made public.
Key Highlights
- Board meeting scheduled for May 19, 2026, to approve financial results.
- Consideration of Standalone & Consolidated Audited Financial Results.
- Trading window closed until 48 hours after results are public.
Price Impact
More from KPL